US Patent 11332713 Gene-regulating compositions and methods for improved immunotherapy
Patent 11332713 was granted and assigned to KSQ Therapeutics on May, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11332713 Gene-regulating compositions and methods for improved immunotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
